Development of radiotracers for oncology--the interface with pharmacology - Wikidata - wikimedia - TriplyDB

Development of radiotracers for oncology--the interface with pharmacology

Development of radiotracers for oncology--the interface with pharmacology

http://www.wikidata.org/entity/Q35195500

about

Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET Imaging Development and translational imaging of a TP53 porcine tumorigenesis model Clinical, ethical and financial implications of incidental imaging findings: experience from a phase I trial in healthy elderly volunteers.New frontiers in the design and synthesis of imaging probes for PET oncology: current challenges and future directions.Status and trends in the development of clinical diagnostic agents.Imaging--the interface with pharmacology: looking to the future.Treatment response assessment with (R)-[11CPAQ PET in the MMTV-PyMT mouse model of breast cancer.

P2860

Q26774478-5A44D109-DB04-497B-8F7A-4CDFF80548A0 Q34117482-5A2A7065-6CC0-4559-9C77-3466957D9927 Q34482802-B7CACD9F-9EF9-4366-812B-5309EBFA1DCD Q38040666-0395C8F9-7576-4F44-98B7-EDDFAC17A5CF Q38995734-8F6116B4-591E-4E12-9416-E8747DCF29DD Q45327311-FF73DAE0-0E35-46C9-935B-9AB8D8A42B42 Q55262619-B6B80BCE-7325-48DA-926E-28C1259DEB8F

P2860

Development of radiotracers for oncology--the interface with pharmacology

http://www.wikidata.org/entity/Q35195500

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Development of radiotracers for oncology--the interface with pharmacology

@ast

Development of radiotracers for oncology--the interface with pharmacology

@en

type

label

Development of radiotracers for oncology--the interface with pharmacology

@ast

Development of radiotracers for oncology--the interface with pharmacology

@en

prefLabel

Development of radiotracers for oncology--the interface with pharmacology

@ast

Development of radiotracers for oncology--the interface with pharmacology

@en

P1433

Q35195500-1A42FBC7-55FD-4BF6-BECD-192CEFBEBD99

P1476

Q35195500-EB033A48-AF07-4FE0-B070-159CCD9CA66A

P2093

Q35195500-2F5DFD57-55B3-457F-9772-68A716B7AF3C

Q35195500-47E9B28E-9FA8-45BF-BCB7-A69DEEC7BA7C

P2860

Q35195500-0120D40A-71BE-4CA9-91D0-3473C23F81E0

Q35195500-0247A1D7-80DF-49BB-B350-552E34DBFD27

Q35195500-0312F5CD-16BE-480D-AD44-1ECCFA465EFB

Q35195500-0F53F895-FF15-4D69-884C-504CF86F2A36

Q35195500-100B481C-A892-4B41-8F21-D10364F46265

Q35195500-10D799EC-B27E-4B39-8B2F-75215A06EF0F

Q35195500-1296ECE7-65A9-47F6-B36C-BC8B39E7CD61

Q35195500-16165E1B-C2D5-43AA-BE11-9E587C4A162A

Q35195500-21DA69A3-E4E3-4F04-9697-919E51DC6836

Q35195500-2465075F-7E6C-4909-85DF-E6C10EBD7200

P304

Q35195500-BB82B668-2324-45BA-86A1-4C919F451FC9

P31

Q35195500-4a9cb33e-d619-4750-aafe-10667b20f5e4

Q35195500-F51CC213-E80B-49DF-8673-33AC82CE6EE0

P356

Q35195500-F7ECDE64-CB41-443C-B219-2499E419D7AC

P407

Q35195500-BC63F876-9C23-4EEB-AE4C-D01C1E91143B

P433

Q35195500-863C795E-EFE0-49C9-A0B0-9406134F1BAC

P478

Q35195500-DDFFF0FF-7F9D-4DAF-9195-0543C7119D58

P577

Q35195500-8F50D5E8-326A-4A47-A35E-3EEB72B95651

P5875

Q35195500-8D48EB6A-0139-438A-8C76-4F2731601B6C

P698

Q35195500-BB8DBE87-D6EF-4D99-93D3-A77DEBA5F103

P932

Q35195500-A786B17E-D4E9-45B4-9211-D3DA9A113FC9

P356

J.1476-5381.2010.01160.X

P1433

British Journal of Pharmacology

P1476

Development of radiotracers for oncology--the interface with pharmacology

@en

P2093

Eric Aboagye

http://www.w3.org/2001/XMLSchema#string

Rohini Sharma

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers

Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development

Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis

Regulation of human thymidine kinase during the cell cycle

Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.

Pharmacokinetic evaluation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography.

Use of 3'-deoxy-3'-[18F]fluorothymidine PET to monitor early responses to radiation therapy in murine SCCVII tumors.

Design, synthesis, and biological characterization of a caspase 3/7 selective isatin labeled with 2-[18F]fluoroethylazide.

Early detection of erlotinib treatment response in NSCLC by 3'-deoxy-3'-[F]-fluoro-L-thymidine ([F]FLT) positron emission tomography (PET).

P304

1565-1585

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.2010.01160.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

163

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49699862

http://www.w3.org/2001/XMLSchema#string

P698

21175573

http://www.w3.org/2001/XMLSchema#string

P932

3166688

http://www.w3.org/2001/XMLSchema#string